CATABASIS PHARMACEUTICALS INC 4/A
4/A · CATABASIS PHARMACEUTICALS INC · Filed Sep 13, 2016
Insider Transaction Report
Form 4/AAmended
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2016-09-08+45,000→ 45,000 totalExercise: $4.31Exp: 2026-09-07→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]This Form 4/A is being filed to correct the stated Conversion or Exercise Price of Derivative Security. The correct Exercise Price of the Derivative Security is $4.31 and was previously stated as $4.30.
- [F2]The option was granted on September 8, 2016 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of September 8, 2016 and the reminder vesting over the ensuing three years at a rate of 2.0833% per month.